Pharsight

GILEAD SCIENCES INC patents facing oppositions

Top patents of GILEAD SCIENCES INC facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP2637664B1 29 Mar, 2017 Compositions and methods of treating pulmonary hypertension Oct, 2031 6
EP4070788B1 22 Mar, 2023 Pharmaceutical formulations Jun, 2036 1
EP4070787B1 01 Mar, 2023 Pharmaceutical formulations Jun, 2036 1
EP3157932B1 10 Jan, 2018 Sodium (2r, 5s, 13ar) -7, 9-dioxo-10- ( (2,4,6-trifluorobenzyl) carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13a-octahydro-2, 5-methanopyrido [1',2' : 4.5]pyrazino [2, 1-b]oxazepin-8-olate Jun, 2035 1